CYTOCHALASIN B

CYTOCHALASIN B is a lipid of Polyketides (PK) class. Cytochalasin b is associated with abnormalities such as Renal tubular disorder and Chagas Disease. The involved functions are known as Membrane Protein Traffic, inhibitors, Metabolic Inhibition, Biochemical Pathway and Increased Sensitivy. Cytochalasin b often locates in Cytoplasmic matrix, Plasma membrane, Microtubules, Extracellular and Protoplasm. The associated genes with CYTOCHALASIN B are SLC2A2 gene, PFDN5 gene, SLC2A1 gene, OMG gene and SPEN gene. The related lipids are Steroids, Lipopolysaccharides and Liposomes. The related experimental models are Xenograft Model.

Cross Reference

Introduction

To understand associated biological information of CYTOCHALASIN B, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with CYTOCHALASIN B?

CYTOCHALASIN B is suspected in Renal tubular disorder, Chagas Disease and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with CYTOCHALASIN B

MeSH term MeSH ID Detail
Erythroblastosis, Fetal D004899 2 associated lipids
CREST Syndrome D017675 2 associated lipids
Factor XII Deficiency D005175 2 associated lipids
Wiskott-Aldrich Syndrome D014923 3 associated lipids
Pharyngeal Neoplasms D010610 4 associated lipids
Pituitary Neoplasms D010911 4 associated lipids
Coronavirus Infections D018352 4 associated lipids
Chancroid D002602 4 associated lipids
Systemic Inflammatory Response Syndrome D018746 4 associated lipids
Granulomatous Disease, Chronic D006105 4 associated lipids
Granulomatosis with Polyangiitis D014890 5 associated lipids
Galactosemias D005693 5 associated lipids
Infectious Mononucleosis D007244 5 associated lipids
Ataxia Telangiectasia D001260 6 associated lipids
Trisomy D014314 6 associated lipids
Adenoma, Islet Cell D007516 7 associated lipids
Lymphoproliferative Disorders D008232 7 associated lipids
Aggressive Periodontitis D010520 8 associated lipids
Carbon Monoxide Poisoning D002249 9 associated lipids
Chondrosarcoma D002813 9 associated lipids
Foreign-Body Reaction D005549 10 associated lipids
Lymphoma, T-Cell D016399 11 associated lipids
Congenital Abnormalities D000013 11 associated lipids
Eye Diseases D005128 12 associated lipids
Hypoglycemia D007003 13 associated lipids
Glucose Intolerance D018149 13 associated lipids
Neutropenia D009503 15 associated lipids
Tongue Neoplasms D014062 15 associated lipids
Thrombocytopenia D013921 15 associated lipids
Burkitt Lymphoma D002051 15 associated lipids
Thymus Neoplasms D013953 15 associated lipids
Leukemia, Myelogenous, Chronic, BCR-ABL Positive D015464 17 associated lipids
Lymphoma D008223 18 associated lipids
Leukemia, Lymphoid D007945 18 associated lipids
Wounds and Injuries D014947 20 associated lipids
Tuberculosis D014376 20 associated lipids
Anemia D000740 21 associated lipids
Hypoxia-Ischemia, Brain D020925 22 associated lipids
Malaria, Falciparum D016778 22 associated lipids
Medulloblastoma D008527 22 associated lipids
Carcinoma 256, Walker D002279 22 associated lipids
Birth Weight D001724 23 associated lipids
Lymphoma, B-Cell D016393 24 associated lipids
Cell Transformation, Viral D002472 26 associated lipids
Hyperinsulinism D006946 27 associated lipids
Insulinoma D007340 28 associated lipids
Kidney Diseases D007674 29 associated lipids
Endometrial Neoplasms D016889 30 associated lipids
Micronuclei, Chromosome-Defective D048629 33 associated lipids
Uremia D014511 33 associated lipids
Per page 10 20 50 100 | Total 79

PubChem Associated disorders and diseases

What pathways are associated with CYTOCHALASIN B

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with CYTOCHALASIN B?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with CYTOCHALASIN B?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with CYTOCHALASIN B?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with CYTOCHALASIN B?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with CYTOCHALASIN B?

Xenograft Model

Xenograft Model are used in the study 'Endofacial competitive inhibition of the glucose transporter 1 activity by gossypol.' (Pérez A et al., 2009).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with CYTOCHALASIN B

Download all related citations
Per page 10 20 50 100 | Total 4982
Authors Title Published Journal PubMed Link
Tanaka Y et al. H-Ras signals to cytoskeletal machinery in induction of integrin-mediated adhesion of T cells. 1999 J. Immunol. pmid:10570313
Owen WF et al. Synthesis and release of leukotriene C4 by human eosinophils. 1987 J. Immunol. pmid:3025300
David JR et al. Antibody-dependent, eosinophil-mediated damage to 51Cr-labeled schistosomula of Schistosoma mansoni: effect of metabolic inhibitors and other agents which alter cell function. 1977 J. Immunol. pmid:193993
Parker CW Pharmacologic modulation of release of arachidonic acid from human mononuclear cells and lymphocytes by mitogenic lectins. 1982 J. Immunol. pmid:6274957
Showell HJ et al. Characterization of the secretory activity of leukotriene B4 toward rabbit neutrophils. 1982 J. Immunol. pmid:6274960
Passwell JH et al. Increased prostaglandin production by human monocytes after membrane receptor activation. 1979 J. Immunol. pmid:448142
Shen Z et al. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. 1997 J. Immunol. pmid:9058806
van der Loo W et al. Cell differentiation in the presence of cytochalasin B: studies on the "switch" to IgG secretion after polyclonal B cell activation. 1979 J. Immunol. pmid:376713
Orange RP Dissociation of the immunologic release of histamine and slow reacting substance of anaphylaxis from human lung using cytochalasins A and B-1. 1975 J. Immunol. pmid:46240
Lipsky PE and Rosenthal AS Macrophage-lymphocyte interaction: antigen-independent binding of guinea pig lymph node lymphocytes by macrophages. 1975 J. Immunol. pmid:50361
Boyle MD et al. Lysis of tumor cells by antibody and complement. III. Lack of correlation between antigen movement and cell lysis. 1975 J. Immunol. pmid:50364
Crockett-Torabi E and Fantone JC Soluble and insoluble immune complexes activate human neutrophil NADPH oxidase by distinct Fc gamma receptor-specific mechanisms. 1990 J. Immunol. pmid:2170530
Rosenthal AS et al. Inhibition of macrophage-lymphocyte interaction by cytochalasin B during antigen recognition by T lymphocytes. 1975 J. Immunol. pmid:51878
Gemsa D et al. Induction of prostaglandin E release from macrophages by colchicine. 1980 J. Immunol. pmid:6243150
Katz P et al. Mechanisms of human cell-mediated cytotoxicity. III. Dependence of natural killing on microtubule and microfilament integrity. 1982 J. Immunol. pmid:6890568
Shaw JO et al. Activation of human neutrophils with 1-O-hexadecyl/octadecyl-2-acetyl-sn-glycerol-3-phosphorylcholine (platelet activating factor). 1981 J. Immunol. pmid:6267133
Tomhave ED et al. Cross-desensitization of receptors for peptide chemoattractants. Characterization of a new form of leukocyte regulation. 1994 J. Immunol. pmid:8089498
Dahinden C and Fehr J Granulocyte activation by endotoxin. II. Role of granulocyte adherence, aggregation, and effect of cytochalasin B, and comparison with formylated chemotactic peptide-induced stimulation. 1983 J. Immunol. pmid:6294179
Kersey JH et al. Human T lymphocyte receptors for sheep erythrocytes: conditions for binding including inhibition by cytochalasin B. 1974 J. Immunol. pmid:4544364
Ferreri NR et al. Release of leukotrienes C4 and B4 and prostaglandin E2 from human monocytes stimulated with aggregated IgG, IgA, and IgE. 1986 J. Immunol. pmid:3009617
Greenberg PD and Bluestein HG Antigen recognition by primed T lymphocytes in vitro. I. Separation of recognitive and proliferative phases of antigen-induced T cell activation. 1978 J. Immunol. pmid:307572
Pichler WJ et al. Fc-receptors on human T lymphocytes. I. Transition of Tgamma to Tmu cells. 1978 J. Immunol. pmid:308968
Tiku K et al. Interleukin 1 production by human polymorphonuclear neutrophils. 1986 J. Immunol. pmid:3084639
Kammer GM et al. Capping of human T cell specific determinants: kinetics of capping and receptor re-expression and regulation by the cytoskeleton. 1983 J. Immunol. pmid:6600189
Martínez-Lorenzo MJ et al. Activated human T cells release bioactive Fas ligand and APO2 ligand in microvesicles. 1999 J. Immunol. pmid:10415024
Hoffman R et al. Effect of cytochalasin B on human lymphocyte responses to mitogens: time and concentration dependence. 1977 J. Immunol. pmid:850072
Williams JD et al. Generation of leukotrienes by human monocytes pretreated with cytochalasin B and stimulated with formyl-methionyl-leucyl-phenylalanine. 1986 J. Immunol. pmid:3001181
Petersen F et al. TNF-alpha renders human neutrophils responsive to platelet factor 4. Comparison of PF-4 and IL-8 reveals different activity profiles of the two chemokines. 1996 J. Immunol. pmid:8596050
Gormus BJ et al. Capping of mouse spleen lymphocyte C3 receptors: effects of pharmacologic agents. 1980 J. Immunol. pmid:7373047
Goldstein IM and Weissmann G Generation of C5-derived lysosomal enzyme-releasing activity (C5a) by lysates of leukocyte lysosomes. 1974 J. Immunol. pmid:4473046
Yasaka T et al. Monocyte aggregation and superoxide anion release in response to formyl-methionyl-leucyl-phenylalanine (FMLP) and platelet-activating factor (PAF). 1982 J. Immunol. pmid:6278021
Roberts RL and La Via MF Inhibition of antigen-induced B lymphocyte activation in vitro by cytochalasin B. 1976 J. Immunol. pmid:778260
Bender JG et al. Independent regulation of human neutrophil chemotactic receptors after activation. 1987 J. Immunol. pmid:2822801
Mookerjee BK and Jung CY The effects of cytochalasins on lymphocytes: mechanism of action of Cytochalasin A on responses to phytomitogens. 1982 J. Immunol. pmid:7061857
Bauldry SA et al. Tumor necrosis factor-alpha priming of phospholipase A2 activation in human neutrophils. An alternative mechanism of priming. 1991 J. Immunol. pmid:1846897
Norton JM and Munck A Glucose transport in murine macrophages: in vitro characterization of the monosaccharide transport system of the thioglycollate-elicited mouse peritoneal macrophage. 1980 J. Immunol. pmid:6991602
Woodruff JJ et al. An in vitro model of lymphocyte homing. II. Membrane and cytoplasmic events involved in lymphocyte adherence to specialized high-endothelial venules of lymph nodes. 1977 J. Immunol. pmid:410878
Ziegler HK et al. Studies on the cytolytic activity of human lymphocytes. III. An analysis of requirements for K cell-target interaction. 1977 J. Immunol. pmid:410884
Cassatella MA et al. IL-8 production by human polymorphonuclear leukocytes. The chemoattractant formyl-methionyl-leucyl-phenylalanine induces the gene expression and release of IL-8 through a pertussis toxin-sensitive pathway. 1992 J. Immunol. pmid:1578146
Murakami S et al. Inducible binding of human lymphocytes to hyaluronate via CD44 does not require cytoskeleton association but does require new protein synthesis. 1994 J. Immunol. pmid:7506725
Peacock JS and Barisas BG Photobleaching recovery studies of antigen-specific mouse lymphocyte stimulation by DNP-conjugated polymerized flagellin. 1981 J. Immunol. pmid:6167632
Henson PM et al. Intracellular control of human neutrophil secretion. II. Stimulus specificity of desensitization induced by six different soluble and particulate stimuli. 1981 J. Immunol. pmid:7019331
Grossi CE et al. Ontogeny of B cells in the chicken. II. Changing patterns of cytoplasmic IgM expression and of modulation requirements for surface IgM by anti-mu antibodies. 1977 J. Immunol. pmid:407304
Uzgiris EE et al. Oscillation of cell surface charge of human peripheral blood lymphocytes after stimulation with concanavalin A. 1982 J. Immunol. pmid:7199546
Hébert CA et al. Endothelial and leukocyte forms of IL-8. Conversion by thrombin and interactions with neutrophils. 1990 J. Immunol. pmid:2212672
Abbas AK T lymphocyte-mediated suppression of myeloma function in vitro. I. Suppression by allogeneically activated T lymphocytes. 1979 J. Immunol. pmid:114584
Sandberg G The sealed capillary migration technique and thymocyte migration in vitro. 1976 J. Immunol. Methods pmid:1085786
Verschueren H et al. Methods for computer assisted analysis of lymphoid cell shape and motility, including Fourier analysis of cell outlines. 1993 J. Immunol. Methods pmid:8335964
Ohara J et al. Purification of cytoplasts (enucleated cells) and karyoplasts (nuclei) from mouse splenic lymphocytes with cytochalasin-B. 1981 J. Immunol. Methods pmid:6169767
Lombard Y et al. A new method for studying the binding and ingestion of zymosan particles by macrophages. 1994 J. Immunol. Methods pmid:8083517
Palmblad J et al. The quantification of neutrophil orientation and migration under agarose--a new method for detecting directed and random movements. 1981 J. Immunol. Methods pmid:7252175
MacFarlane GD and Herzberg MC Concurrent estimation of the kinetics of adhesion and ingestion of Staphylococcus aureus by human polymorphonuclear leukocytes (PMNs). 1984 J. Immunol. Methods pmid:6420472
Giaimis J et al. A new and simple method for studying the binding and ingestion steps in the phagocytosis of yeasts. 1992 J. Immunol. Methods pmid:1383342
Mege JL et al. Study of cell deformability by a simple method. 1985 J. Immunol. Methods pmid:3928763
Haynes AP et al. A novel flow cytometric method for measuring protein digestion within the phagocytic vacuole of polymorphonuclear neutrophils. 1990 J. Immunol. Methods pmid:2273255
Sveum RJ et al. A quantitative fluorescent method for measurement of bacterial adherence and phagocytosis. 1986 J. Immunol. Methods pmid:3722828
Yoshinari K et al. Long-term production of human monoclonal antibodies by human-mouse heterohybridomas. 1995 J. Immunol. Methods pmid:7561144
Zimmerli W et al. The role of formylpeptide receptors, C5a receptors, and cytosolic-free calcium in neutrophil priming. 1990 J. Infect. Dis. pmid:2153739
Galgiani JN et al. Leukocyte effects on the dimorphism of Coccidioides immitis. 1982 J. Infect. Dis. pmid:7086205
Brito GA et al. Clostridium difficile toxin A alters in vitro-adherent neutrophil morphology and function. 2002 J. Infect. Dis. pmid:12001047
Kan VL and Bennett JE Lectin-like attachment sites on murine pulmonary alveolar macrophages bind Aspergillus fumigatus conidia. 1988 J. Infect. Dis. pmid:3042877
Peterson PK et al. Human peritoneal macrophage cytotoxicity mediated by cytophilic IgG. 1983 J. Infect. Dis. pmid:6655286
Benach JL et al. Interactions of phagocytes with the Lyme disease spirochete: role of the Fc receptor. 1984 J. Infect. Dis. pmid:6386995
Zhang B et al. Penicillin G-induced microbicidal activity of endothelial cells cultured on gelfoam blocks. 1996 J. Infect. Dis. pmid:8896501
Yamamoto A et al. Cadmium stimulates glucose metabolism in rat adipocytes. 1986 J. Inorg. Biochem. pmid:3531403
Mattila JT et al. Phagocytosis of the Lyme disease spirochete, Borrelia burgdorferi, by cells from the ticks, Ixodes scapularis and Dermacentor andersoni, infected with an endosymbiont, Rickettsia peacockii. 2007 J. Insect Sci. pmid:20331397
Ritzenthaler JD and Roman J Interleukin-1beta gene transcription in U937 cells is modulated by type I collagen and cytoskeletal integrity via distinct signaling pathways. 2001 J. Interferon Cytokine Res. pmid:11244575
Svitlik C and Marcus PI Interferon induction by viruses. XI. Early events in the induction process. 1984 J. Interferon Res. pmid:6209349
Balint E et al. Cytoskeletal modulation of plasma membrane events induced by interferon-alpha. 1992 J. Interferon Res. pmid:1331257
Bukholm G et al. Interferon-induced protein synthesis inhibits endocytosis of bacteria in epithelial cells. 1987 J. Interferon Res. pmid:3312425
Kitajima Y et al. Reorganization of keratin intermediate filaments by the drug-induced disruption of microfilaments in cultured human keratinocytes. 1986 J. Invest. Dermatol. pmid:2430025
Morioka S et al. Migrating keratinocytes express urokinase-type plasminogen activator. 1987 J. Invest. Dermatol. pmid:2435817
Glinski W et al. Reduced expression of surface receptors for synthetic N-formylated chemotactic oligopeptides by stimulated peripheral blood neutrophils in psoriasis. 1987 J. Invest. Dermatol. pmid:3668297
Novales RR The effect of the divalent cation ionophore A23187 on amphibian melanophores and iridophores. 1977 J. Invest. Dermatol. pmid:333033
Patel HP et al. Demonstration of pemphigus antibodies on the cell surface of murine epidermal cell monolayers and their internalization. 1984 J. Invest. Dermatol. pmid:6389716
Cowin AJ et al. Differential effect of wounding on actin and its associated proteins, paxillin and gelsolin, in fetal skin explants. 2003 J. Invest. Dermatol. pmid:12787143
Hönigsmann H et al. Immediate pigment darkening phenomenon. A reevaluation of its mechanisms. 1986 J. Invest. Dermatol. pmid:3772158
Iizuka H et al. Colchicine-induced alteration of hormone-stimulated cyclic AMP synthesis in pig skin (epidermis). 1984 J. Invest. Dermatol. pmid:6323587
Spilberg I et al. Calcium pyrophosphate dihydrate (CPPD) crystal-induced chemotactic factor: subcellular localization, role of protein synthesis and phagocytosis. 1977 J. Lab. Clin. Med. pmid:191547
Muhlfelder TW et al. Factors influencing the release of procoagulant-tissue factor activity from leukocytes. 1978 J. Lab. Clin. Med. pmid:659965
Sagone AL et al. Characteristics of the metabolic response of human monocytes to red cells sensitized with anti-D alloantibodies. 1981 J. Lab. Clin. Med. pmid:6790643
Markert M et al. Activation of the human neutrophil respiratory burst by an anion channel blocker. 1988 J. Lab. Clin. Med. pmid:2452224
Harfenist EJ et al. Inhibitors of ADP-induced platelet aggregation prevent fibrinogen binding to rabbit platelets and cause rapid deaggregation and dissociation of bound fibrinogen. 1981 J. Lab. Clin. Med. pmid:6783712
Niewiarowski S and Goldstein S Interaction of cultured human fibroblasts with fibrin: modification by drugs and aging in vitro. 1973 J. Lab. Clin. Med. pmid:4356885
Smolen JE Lag period for superoxide anion generation and lysosomal enzyme release from human neutrophils: effects of calcium antagonists and anion channel blockers. 1984 J. Lab. Clin. Med. pmid:6330249
Spilberg I et al. Studies on crystal-induced chemotactic factor. II. Role of phagocytosis. 1975 J. Lab. Clin. Med. pmid:1120930
Cazenave JP et al. Inhibition of platelet adherence to a collagen-coated surface by agents that inhibit platelet shape change and clot retraction. 1974 J. Lab. Clin. Med. pmid:4370106
Oseas RS et al. Differences in polymorphonuclear leukocyte aggregating responses among several species in response to chemotactic stimulation. 1980 J. Lab. Clin. Med. pmid:7400660
Koukouritaki SB and Lianos EA Glucocorticoid effect on human mesangial cell cytoskeletal proteins. 1999 J. Lab. Clin. Med. pmid:10218769
Wolach B et al. Correlation of in vitro and in vivo effects of gold compounds on leukocyte function: possible mechanisms of action. 1982 J. Lab. Clin. Med. pmid:6283001
Smith CM et al. Filtration deformability of rabbit pulmonary macrophage. 1982 J. Lab. Clin. Med. pmid:7038013
Rinehart JJ and Boulware T Microfilament and microtubule function in human monocytes. 1977 J. Lab. Clin. Med. pmid:561822
Steiner RD et al. Cytochalasin B facilitates the inhibition of human polymorphonuclear leukocyte generation of superoxide by verapamil. 1984 J. Lab. Clin. Med. pmid:6327866
Fantone J et al. Biochemical quantitation of the chemotactic factor inactivator activity in human serum. 1979 J. Lab. Clin. Med. pmid:759526
Craddock PR et al. Potentiation of complement (C5a)-induced granulocyte aggregation by cytochalasin B. 1978 J. Lab. Clin. Med. pmid:564378
García-García E et al. Phosphatidylinositol 3-kinase and ERK are required for NF-kappaB activation but not for phagocytosis. 2001 J. Leukoc. Biol. pmid:11590203
Gay JC and Stitt ES Chemotactic peptide enhancement of phorbol ester-induced protein kinase C activity in human neutrophils. 1990 J. Leukoc. Biol. pmid:2152940
Van Epps DE et al. Modulation of neutrophil-reduced pyridine nucleotide content following stimulation with phorbol myristate acetate and chemotactic factors. 1985 J. Leukoc. Biol. pmid:2995525
Smallwood JI and Malawista SE Protein kinase C isoforms in human neutrophil cytoplasts. 1992 J. Leukoc. Biol. pmid:1311015
Egesten A et al. Phorbol ester-induced degranulation in adherent human eosinophil granulocytes is dependent on CD11/CD18 leukocyte integrins. 1993 J. Leukoc. Biol. pmid:8095965